Gene · 8976
Papers2,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Actin nucleators safeguard replication forks by limiting nascent strand degradation. | Nucleic Acids Res | 2023 | 37224534 | PubTator, text mining | PubMed |
| Microglia degrade Tau oligomers deposit via purinergic P2Y12-associated podosome and filopodia formation and induce chemotaxis. | Cell Biosci | 2023 | 37221563 | PubTator, text mining | PubMed |
| Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS. | Signal Transduct Target Ther | 2023 | 37221195 | PubTator, text mining | PubMed |
| Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK. | J Ethnopharmacol | 2023 | 37196814 | PubTator, text mining | PubMed |
| Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation. | Cell Death Dis | 2023 | 37185904 | PubTator, text mining | PubMed |
| A single chlamydial protein reshapes the plasma membrane and serves as recruiting platform for central endocytic effector proteins. | Commun Biol | 2023 | 37179401 | PubTator, text mining | PubMed |
| Characterizing Intraindividual Podocyte Morphology In Vitro with Different Innovative Microscopic and Spectroscopic Techniques. | Cells | 2023 | 37174644 | PubTator, text mining | PubMed |
| Salmonella invasion of a cell is self-limiting due to effector-driven activation of N-WASP. | iScience | 2023 | 37168569 | PubTator, text mining | PubMed |
| ARPC5 isoforms and their regulation by calcium-calmodulin-N-WASP drive distinct Arp2/3-dependent actin remodeling events in CD4 T cells. | Elife | 2023 | 37162507 | PubTator, text mining | PubMed |
| Legionella pneumophila-mediated host posttranslational modifications. | J Mol Cell Biol | 2023 | 37156500 | PubTator, text mining | PubMed |
| Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction. | Front Immunol | 2023 | 37138877 | PubTator, text mining | PubMed |
| Small GTPase Cdc42, WASP, and scaffold proteins for higher-order assembly of the F-BAR domain protein. | Sci Adv | 2023 | 37126564 | PubTator, text mining | PubMed |
| Oncogenic role of copper‑induced cell death‑associated protein DLD in human cancer: A pan‑cancer analysis and experimental verification. | Oncol Lett | 2023 | 37123026 | PubTator, text mining | PubMed |
| Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development. | J Biol Chem | 2023 | 37100284 | PubTator, text mining | PubMed |
| Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications. | Adv Sci (Weinh) | 2023 | 37080941 | PubTator, text mining | PubMed |
| The IQGAP scaffolds: Critical nodes bridging receptor activation to cellular signaling. | J Cell Biol | 2023 | 37071417 | PubTator, text mining | PubMed |
| Identification of novel biomarkers linking depressive disorder and Alzheimer's disease based on an integrative bioinformatics analysis. | BMC Genom Data | 2023 | 37061663 | PubTator, text mining | PubMed |
| The role of Rho GTPase family in cochlear hair cells and hearing. | Neural Regen Res | 2023 | 37056125 | PubTator, text mining | PubMed |
| MACC1-induced migration in tumors: Current state and perspective. | Front Oncol | 2023 | 37051546 | PubTator, text mining | PubMed |
| High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML. | Cancers (Basel) | 2023 | 37046649 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8976/papers?page=9